Alaunos Therapeutics | ZIOP - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Baxter International USD 6.04B 86M 2026-03
Biogen USD 18.65B 394.9M 2026-03
Bioline Rx USD 19.53M 537K 2025-09
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Celltrion KRW 435.96B 16.26T 2025-12
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Curis USD 5.46M 19.45M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Incyte USD 5.62B 455.37M 2026-03
Intrexon USD 43.17M 75.33M 2024-06
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
J&J USD 81.19B 358M 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Merck USD 45.88B 6.73B 2026-03
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pfizer USD 90.1B 3.63B 2026-03
Pharma Mar EUR 249.67M 2.16M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
TG Therapeutics USD 583.13M 64.89M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Verastem USD 57.2M 72.72M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03